These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10888412)

  • 21. [Deep freezing of oocytes for preserving the fertility of young female oncology patients treated with aggressive radio- and/or chemotherapy].
    Konc J; Kanyó K; Cseh S
    Orv Hetil; 2006 Apr; 147(14):655-8. PubMed ID: 16711373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should cetuximab replace cisplatin in head and neck cancer?
    Rowan K
    J Natl Cancer Inst; 2010 Jan; 102(2):74-6, 78. PubMed ID: 20054019
    [No Abstract]   [Full Text] [Related]  

  • 23. Future development of amifostine as a radioprotectant.
    Werner-Wasik M
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):129-34. PubMed ID: 10348272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoprotective and radioprotective effects of amifostine: an update of clinical trials.
    Capizzi RL; Oster W
    Int J Hematol; 2000 Dec; 72(4):425-35. PubMed ID: 11197208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controversies in the radiotherapeutic management of cervical cancer.
    Koh WJ
    J Clin Oncol; 2003 May; 21(10 Suppl):218s-223s. PubMed ID: 12743138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants.
    Hensley ML; Hagerty KL; Kewalramani T; Green DM; Meropol NJ; Wasserman TH; Cohen GI; Emami B; Gradishar WJ; Mitchell RB; Thigpen JT; Trotti A; von Hoff D; Schuchter LM
    J Clin Oncol; 2009 Jan; 27(1):127-45. PubMed ID: 19018081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the Effectiveness of a Multimodal Complementary Medicine Program for Improving the Quality of Life of Cancer Patients during Adjuvant Radiotherapy and/or Chemotherapy or Outpatient Aftercare.
    Domnick M; Domnick M; Wiebelitz KR; Beer AM
    Oncology; 2017; 93(2):83-91. PubMed ID: 28472802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exercise and side effects among 749 patients during and after treatment for cancer: a University of Rochester Cancer Center Community Clinical Oncology Program Study.
    Mustian KM; Griggs JJ; Morrow GR; McTiernan A; Roscoe JA; Bole CW; Atkins JN; Issell BF
    Support Care Cancer; 2006 Jul; 14(7):732-41. PubMed ID: 16482444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology.
    Schuchter LM; Hensley ML; Meropol NJ; Winer EP;
    J Clin Oncol; 2002 Jun; 20(12):2895-903. PubMed ID: 12065567
    [No Abstract]   [Full Text] [Related]  

  • 30. Proceedings of the Fourth International Cytoprotection Investigators' Congress. May 2004. Philadelphia, Pennsylvania, USA.
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):1-73. PubMed ID: 15801121
    [No Abstract]   [Full Text] [Related]  

  • 31. Mucositis: pathobiology and management.
    Villa A; Sonis ST
    Curr Opin Oncol; 2015 May; 27(3):159-64. PubMed ID: 25774860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospects.
    Hospers GA; Eisenhauer EA; de Vries EG
    Br J Cancer; 1999 May; 80(5-6):629-38. PubMed ID: 10360638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Development of cancer chemotherapy. Cytoprotective agents].
    Lopez M
    Clin Ter; 2001; 152(2):135-43. PubMed ID: 11441524
    [No Abstract]   [Full Text] [Related]  

  • 34. The potential of amifostine: from cytoprotectant to therapeutic agent.
    Santini V; Giles FJ
    Haematologica; 1999 Nov; 84(11):1035-42. PubMed ID: 10553165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimum cancer care--an unaffordable goal?
    Thorat M
    Lancet Oncol; 2004 Sep; 5(9):530. PubMed ID: 15337481
    [No Abstract]   [Full Text] [Related]  

  • 36. Chemoprotection in anticancer therapy: the emerging role of amifostine (WR-2721).
    Kurbacher CM; Mallmann PK
    Anticancer Res; 1998; 18(3C):2203-10. PubMed ID: 9703784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer treatments and their side effects are associated with aggravation of insomnia: Results of a longitudinal study.
    Savard J; Ivers H; Savard MH; Morin CM
    Cancer; 2015 May; 121(10):1703-11. PubMed ID: 25677509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer.
    Kirwan JM; Symonds P; Green JA; Tierney J; Collingwood M; Williams CJ
    Radiother Oncol; 2003 Sep; 68(3):217-26. PubMed ID: 13129628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can the therapeutic gain of radiotherapy be increased by concurrent administration of Asian botanicals?
    Sagar SM
    Integr Cancer Ther; 2010 Mar; 9(1):5-13. PubMed ID: 20042406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Assessment of mucosal injury in stage T1-T2NOMO bladder cancer after radiation or intravesical chemotherapy].
    Kaprin AD; Panyshin GA; Garmash SV; Kostin AA; Khmelevskiĭ EV; Elagin VO
    Vopr Onkol; 2008; 54(1):98-101. PubMed ID: 18416068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.